MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EMMA has $18,696K in assets. $86,556K in debts. $1,072K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
8.50%
Quick Ratio
5.79%
Cash Ratio
1.52%
Debt to Asset Ratio
462.97%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investment in convertible bond
    • Accounts receivable, net
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
1,072 2,127 293 886
Accounts receivable, net
2,048 2,804 2,619 2,071
Inventories, net
1,909 1,555 1,213 1,313
Prepaid expenses and other current assets
966 1,260 661 745
Total current assets
5,995 7,746 4,786 5,015
Property and equipment, gross
469 469 509 -
Less accumulated depreciation
371 356 381 -
Property and equipment, net
98 113 128 143
Right of use assets
736 766 799 830
Investment in convertible bond
11,664 12,604 14,876 17,188
Other assets
203 207 167 168
Total assets
18,696 21,436 20,756 23,344
Accounts payable and accrued expenses
24,487 22,615 21,759 19,373
Operating lease liabilities, current portion
349 348 348 348
Conversion feature derivative, notes payable
235 0 --
Other current liabilities
17,443 17,565 14,475 14,139
Warrant derivative liabilities
15 13 11 13
Notes payable to related parties-Nonrelated Party
7,529 8,019 7,640 8,267
Notes payable to related parties-Related Party
3,123 3,132 3,132 3,132
Convertible notes payable, net of discount
17,356 17,380 16,804 16,804
Total current liabilities
70,537 69,072 64,169 62,076
Operating lease liabilities, less current portion
1,324 1,409 1,498 1,584
Other long-term liabilities
12,418 12,292 12,313 13,128
Notes payable to related parties, net of discount
2,277 2,271 2,264 2,257
Total liabilities
86,556 85,044 80,244 79,045
Common stock, par value 0.001 per share, 250,000,000 shares authorized, 70,188,263 shares issued and outstanding at march 31, 2026 2026 and december 31, 2025, respectively
70 70 64 64
Additional paid-in capital
225,988 225,987 225,914 225,905
Net loan receivable from ej holdings
16,869 16,869 16,869 16,869
Accumulated other comprehensive loss
-3,647 -2,729 -481 1,239
Accumulated deficit
-273,402 -270,067 -268,116 -266,040
Total stockholders deficit
-67,860 -63,608 -59,488 -55,701
Total liabilities and stockholders' deficit
18,696 21,436 20,756 23,344
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$2,048K Inventories, net$1,909K Cash and cashequivalents$1,072K Prepaid expenses andother current assets$966K Property and equipment,gross$469K Investment in convertiblebond$11,664K Total current assets$5,995K Right of use assets$736K Other assets$203K Property and equipment,net$98K Less accumulateddepreciation$371K Total assets$18,696K Accumulated deficit-$273,402K Net loan receivablefrom ej holdings$16,869K Accumulated othercomprehensive loss-$3,647K Total liabilities andstockholders' deficit$18,696K Total stockholdersdeficit-$67,860K Additional paid-in capital$225,988K Common stock, par value0.001 per share,...$70K Total liabilities$86,556K Total currentliabilities$70,537K Other long-termliabilities$12,418K Notes payable torelated parties, net of...$2,277K Operating leaseliabilities, less current...$1,324K Accounts payable andaccrued expenses$24,487K Other currentliabilities$17,443K Convertible notes payable,net of discount$17,356K Notes payable torelated...$7,529K Notes payable torelated...$3,123K Operating leaseliabilities, current portion$349K Conversion featurederivative, notes payable$235K Warrant derivativeliabilities$15K

Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences, Inc. (EMMA)